US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 5.550
- -0.060-1.07%
Close Apr 18 16:00 ET
- 5.610
- +0.060+1.08%
Post 19:42 ET
456.40MMarket Cap-2747P/E (TTM)
5.680High5.511Low1.72MVolume5.600Open5.610Pre Close9.59MTurnover2.25%Turnover RatioLossP/E (Static)82.23MShares11.91052wk High1.31P/B424.06MFloat Cap5.51152wk Low--Dividend TTM76.41MShs Float99.950Historical High--Div YieldTTM3.01%Amplitude5.511Historical Low5.590Avg Price1Lot Size
About Editas Medicine Company
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolEDIT
Company NameEditas Medicine
Listing DateFeb 3, 2016
Issue Price16.00
Founded2013
CEODr. Gilmore O’Neill, M.B.
MarketNASDAQ
Employees265
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11 Hurley Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-401-9000
Company Executives
- Name
- Position
- Salary
- Dr. Gilmore O’Neill, M.B.
- Director, Chief Executive Officer and President
- 2.39M
- Baisong Mei, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.14M
- Linda Burkly
- Executive Vice President and Chief Scientific Officer
- 1.54M
- Erick J. Lucera, C.F.A.
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 2.22M
- Emma Reeve
- Chairman of the Board
- 238.24K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 264.88K
- Andrew J. Hirsch
- Independent Director
- 210.56K
- Dr. Jessica Hopfield, PhD
- Lead Independent Director
- 231.07K
- Dr. Meeta Chatterjee, PhD
- Independent Director
- 205.56K
- Dr. Akshay K. Vaishnaw, M.D.,PhD
- Independent Director
- 208.06K
- Bernadette M. Connaughton
- Independent Director
- 215.06K
- Dr. David T. Scadden, M.D.
- Independent Director
- 213.06K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
